Quantcast
Last updated on April 17, 2014 at 1:21 EDT

NxStage Board Member Dr. Barry M. Straube Honored by National Renal Administrators Association (NRAA)

November 2, 2011

LAWRENCE, Mass., Nov. 2, 2011 /PRNewswire/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Barry M. Straube, M.D., a member of its Board of Directors, was honored with the Mark Zawiski Memorial Award from the National Renal Administrators Association (NRAA). The award honors outstanding leadership in the End Stage Renal Disease (ESRD) community and was presented at the NRAA annual conference in New Orleans.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

Mark Zawiski was an important leader in renal care, serving the NRAA and participating in dialysis policy work including helping to develop some of the first software solutions for ESRD cost reporting. The award accepts nominations from NRAA members and recognizes other outstanding leaders within the kidney community, voted on by a panel of past recipients.

“During my time as Chief Medical Officer for the Centers for Medicare & Medicaid Services (CMS), NRAA was an important source of leadership and advocacy for the ESRD community. We worked collaboratively to develop programs that encourage better care, including the provision of home hemodialysis services,” said Dr. Straube. “To receive an award inspired by Mark Zawiski and his achievements is humbling, and I am deeply grateful to the NRAA and past honorees for this recognition.”

Dr. Straube is the immediate past Chief Medical Officer for the Centers for Medicare & Medicaid Services (CMS), as well as the immediate past director of the CMS Office of Clinical Standards & Quality (OCSQ). Among his many diverse duties at CMS, he chaired the End Stage Renal Disease (ESRD) and Clinical Laboratory Open Door Forum and acted as a senior advisor on ESRD and transplantation issues to the agency. He is a board-certified nephrologist and led CMS efforts in kidney quality metrics development and use, kidney disease quality improvement initiatives, development of the ESRD bundled payment and Quality Incentive Programs, creation of the CROWNWeb ESRD data collection initiative, and many other initiatives focused on improving the quality and value of care delivered to patients with kidney disease.

For more information on the Mark Zawiski Award visit the NRAA website at www.nraa.org/zawiski.php.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. NxStage is leading the development of the home hemodialysis market in the US with the only portable hemodialysis machine, the System One, cleared for home use by the FDA. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com/.

Media Contacts:
Kristen Sheppard, Esq.
Vice President, Investor Relations
NxStage Medical, Inc.
978-332-5923

SOURCE NxStage Medical, Inc.


Source: PR Newswire